(Q54658382)

2 June 2018

title

Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. (English)

1 reference

2 June 2018

author name string

Wilkerson MJ

1

1 reference

2 June 2018

Dolce K

2

1 reference

2 June 2018

Koopman T

3

1 reference

2 June 2018

Shuman W

4

1 reference

2 June 2018

Chun R

5

1 reference

2 June 2018

Garrett L

6

1 reference

2 June 2018

Barber L

7

1 reference

2 June 2018

Avery A

8

1 reference

2 June 2018

publication date

1 July 2005

1 reference

2 June 2018

Veterinary Immunology and Immunopathology

published in

1 reference

2 June 2018

volume

106

1 reference

2 June 2018

page(s)

179-196

1 reference

2 June 2018

issue

3-4

1 reference

2 June 2018

Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Immunohistochemical examination of light-chain expression (lambda/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Molecular methods to distinguish reactive and neoplastic lymphocyte expansions and their importance in transitional neoplastic states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Current concepts. B lymphocytes. Normal development and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other specie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Prognostic variables in canine multicentric lymphosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Lymphocyte subsets in peripheral blood of dogs--a flow cytometric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Lymphomas in dogs. A morphologic, immunologic, and clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Gene rearrangements in T-cell lymphoblastic lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

What can we learn from leukemia as for the process of lineage commitment in hematopoiesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Developmental biology of T cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Prognostic factors for malignant lymphoma in the dog: an update

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Molecular cytogenetic analysis of a novel high-grade canine T-lymphoblastic lymphoma demonstrating co-expression of CD3 and CD79a cell markers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.02.020

10.1016/J.VETIMM.2005.02.020

7 January 2021

Identifiers

DOI

1 reference

2 June 2018

PubMed ID

15963817

1 reference

2 June 2018